SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Park Ha Biological Technology Co., Ltd. (PHH) trades at a trailing P/E of 21.0. Trailing earnings yield is 4.75%.
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (21.0); earnings yield beats bond yields (4.75%).
- Trailing Earnings Yield 4.75% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 79/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PHH
Valuation Multiples
P/E (TTM)21.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.23
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.02
Book Value / Share$0.00
Revenue / Share$0.09
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.75%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$0.56 |
$2.74B |
$34M |
1.2% |
| 2013 |
$2.06 |
$2.84B |
$135M |
4.8% |
| 2014 |
$-3.36 |
$639M |
$-185M |
-29% |
| 2015 |
$-2.37 |
$790M |
$-131M |
-16.6% |
| 2016 |
$-3.60 |
$622M |
$-193M |
-31% |
| 2017 |
$-4.14 |
$456M |
$-194M |
-42.5% |
| 2021 |
$-0.02 |
$931.04K |
$-485K |
-52.1% |
| 2022 |
$0.01 |
$1.92M |
$191.3K |
10% |
| 2023 |
$0.03 |
$2.46M |
$852.04K |
34.6% |
| 2024 |
$0.02 |
$2.38M |
$478.56K |
20.1% |
